Winter Park, Florida–(Newsfile Corp. – February 16, 2026) – Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine and innovative therapeutic solutions, today announced that its subsidiary, Adia Med of Winter Park, LLC, has submitted its second clinical study for Institutional Review Board (IRB) review. This pivotal study will evaluate the efficacy of AdiaVita, Adia Med’s proprietary umbilical cord blood-derived stem cell and exosome product, in alleviating lower back pain through
Adia Nutrition Announces Subsidiary Adia Med’s Submission of Second Clinical Study for IRB Review Targeting Lower Back Pain with AdiaVita
Latest from Blog
Free Nutrition Counseling Sign-Up
The Ohio University Nutrition Treatment Program is now accepting clients for Spring 2026. The program consists of three one-on-one nutritional counseling sessions with a senior dietetic student. Ses Post Views: 2
France’s 2030 food, nutrition and climate strategy promotes fiber and locally grown foods
France has introduced its 2030 national strategy for healthy, sustainable food by combining food, nutrition, and climate. Alongside promoting fiber-forward diets, it encourages consuming more locally grown and seasonal plant-based foods and
MEDICAL MONDAY: Effect of nutrition on Alzheimer’s and Multiple Sclerosis
Nutrition is the foundation, that’s what Dr. John Lewis says in this week’s Medical Monday. Post Views: 2
It’s official—nutrition experts say that freezing bread changes its impact on the body, surprising many
If you are one of those who buys bread, a lot of bread, to keep it frozen for a while and not have to go outside to get it on a bad
AdiaVita stem cell IV trial charges patients $5,000 for back pain
New 100-patient trial will test AdiaVita IV for lower back pain at $5,000 per person, a less invasive option that builds on Adia’s 24‑month autism study. Post Views: 2